Álvaro Arjona-Sánchez at Reina Sofía University Hospital - Research Interests, Publications & Academic Profile

Álvaro Arjona-Sánchez

University Name

Spain

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

Send an email

ORCID

Google Scholar

Research Interests

Surgery

40%

Internal Medicine

70%

Peritoneal Dialysis

80%

Ovarian Cancer

70%

Neoadjuvant Therapy

50%

Gastrointestinal Surgery

40%

Oncology

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Caracterización y validación de nuevas dianas de diagnóstico, de pronóstico y terapéuticas en Pseudomixoma peritoneal

Open Date: 2023-01-01

Close Date: 2026-01-01

Grant: Close

Validation of new therapeutic targets for a rare malignant disease: The Pseudomyxoma Peritonei

Open Date: 2022-09-01

Close Date: 2025-09-01

Grant: Close

Bromelina + N-Acetilcisteína intratumoral en Pseudomixoma Peritoneal recidivado e irresecable. Estudio Fase I/II de brazo único

Open Date: 2021-01-01

Close Date: 2022-12-01

Grant: Close

Caracterización molecular del pseudomixoma peritoneal y desarrollo de biomarcadores y terapias diana en un modelo de raton con xenoimplante humano

Open Date: 2019-12-01

Close Date: 2022-12-01

Grant: Close

Estudio Multicéntrico, Randomizado, para Evaluar el Efecto Adyuvante de la Quimioterapia Intraperitoneal en Hipertermia (Hipec) Con Mitomicina C Asociada A Cirugía Frente A Cirugía Sola en el Carcinoma Colorrectal Localmente Avanzado

Open Date: 2018-10-01

Close Date: 2021-10-01

Articles11

Intra-tumoural bromelain and <i>N</i>-acetylcysteine for recurrent and unresectable pseudomyxoma peritonei: phase I/II trial

Article Link

Year:

2024

Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study

Article Link

Year:

2023

Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer

Article Link

Year:

2023

Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

Article Link

Year:

2023

Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis

Article Link

Year:

2023

Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry

Article Link

Year:

2023

External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification

Article Link

Year:

2023

In favour of prophylactic hyperthermic intraperitoneal chemotherapy for colorectal cancer

Article Link

Year:

2023

Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I/II controlled trial

Article Link

Year:

2023

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Urothelial Origin: a Case Report and Literature Review

Article Link

Year:

2023

Metachronous peritoneal metastases in patients with pT4b colon cancer: An international multicenter analysis of intraperitoneal versus retroperitoneal tumor invasion

Article Link

Year:

2022

Collaborators10

Berta Díaz-Feijoo

PROFESORA ASOCIADA

University of Barcelona

SPAIN

Enrique Aranda Aguilar

Profesor Titular de Universidad

Universidad de Córdoba

SPAIN

Shoma Barat

Conjoint Associate Lecturer

University of New South Wales - Randwick Campus

AUSTRALIA

Carmen Ruiz de Valbuena Bueno

Profesora Asociada

Universidad Rey Juan Carlos - Campus de Fuenlabrada

SPAIN

Ruth Vera

Chief of the department

Hospital Universitari Arnau de Vilanova

SPAIN

Antoni Llueca

Professor

SPAIN

Antonio Gil-Moreno

University of Barcelona

SPAIN

Antonio Sommariva

Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico

ITALY

Juan José Segura-Sampedro

Profesor

SPAIN

Santiago González-Moreno

ADJUNCT PROFESSOR

The University of Texas MD Anderson Cancer Center

UNITED STATES

How do Indian students reach out?

Meet Kite AI